Coramaze Technologies

📍 Petach Tikva, Israel🗓 Founded 2013👥 12 employees💰 Last funded Jul 2019
Coramaze Technologies develops the Tripair, a device repairing functional Tricuspid Regurgitation (fTR) in heart failure patients, to improve quality of life and reduce morbidity. The Tripair implant is anchored a-traumatically in the right atrium, enabling full retrievability and intra-procedural efficacy evaluation.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2013
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in Coramaze Technologies?
Coramaze Technologies has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Coramaze Technologies last raise funding?
The most recent investment in Coramaze Technologies recorded on gritt.io was in July 2019.
When was Coramaze Technologies founded?
Coramaze Technologies was founded in 2013.
What industry is Coramaze Technologies in?
Coramaze Technologies operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Coramaze Technologies based?
Coramaze Technologies is headquartered in Petach Tikva, Israel.